Rory Landon Cochran, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Personnel Selection | 1 | 2021 | 189 | 0.680 |
Why?
|
Magnetic Resonance Angiography | 1 | 2023 | 1441 | 0.560 |
Why?
|
DNA, Neoplasm | 5 | 2017 | 1754 | 0.460 |
Why?
|
Loss of Heterozygosity | 2 | 2014 | 678 | 0.430 |
Why?
|
Research | 1 | 2021 | 2001 | 0.430 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1100 | 0.370 |
Why?
|
BRCA2 Protein | 1 | 2014 | 788 | 0.340 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1143 | 0.330 |
Why?
|
Breast Neoplasms | 11 | 2017 | 20676 | 0.320 |
Why?
|
Students, Medical | 1 | 2021 | 1850 | 0.310 |
Why?
|
Balloon Occlusion | 2 | 2019 | 126 | 0.310 |
Why?
|
Polymerase Chain Reaction | 5 | 2017 | 6174 | 0.310 |
Why?
|
Radiology | 1 | 2021 | 2080 | 0.290 |
Why?
|
Models, Genetic | 1 | 2015 | 3493 | 0.260 |
Why?
|
Placenta Accreta | 2 | 2019 | 225 | 0.260 |
Why?
|
Centrosome | 2 | 2015 | 198 | 0.240 |
Why?
|
Phlebography | 1 | 2023 | 333 | 0.210 |
Why?
|
Mutation | 10 | 2017 | 29658 | 0.210 |
Why?
|
Genomic Instability | 3 | 2017 | 688 | 0.200 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2017 | 888 | 0.200 |
Why?
|
Internship and Residency | 1 | 2021 | 5761 | 0.190 |
Why?
|
Occipital Lobe | 1 | 2021 | 381 | 0.170 |
Why?
|
Cell Cycle | 3 | 2017 | 2960 | 0.160 |
Why?
|
Extremities | 1 | 2023 | 849 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2015 | 2933 | 0.150 |
Why?
|
Breast | 3 | 2017 | 1950 | 0.150 |
Why?
|
Radiology, Interventional | 1 | 2021 | 460 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2021 | 411 | 0.140 |
Why?
|
Dogs | 1 | 2021 | 3915 | 0.140 |
Why?
|
Thymosin | 1 | 2015 | 47 | 0.140 |
Why?
|
Iliac Artery | 1 | 2017 | 363 | 0.140 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 259 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 35326 | 0.140 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1129 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2948 | 0.130 |
Why?
|
Heredity | 1 | 2015 | 153 | 0.130 |
Why?
|
Chromosomes, Human, Y | 1 | 2015 | 147 | 0.130 |
Why?
|
Cell Proliferation | 8 | 2022 | 10455 | 0.130 |
Why?
|
Phlebotomy | 1 | 2015 | 142 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1812 | 0.120 |
Why?
|
Hydrolases | 1 | 2014 | 140 | 0.120 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 897 | 0.120 |
Why?
|
Heterozygote | 3 | 2015 | 2798 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2016 | 8400 | 0.120 |
Why?
|
Receptor, erbB-3 | 1 | 2014 | 142 | 0.120 |
Why?
|
Breast Neoplasms, Male | 1 | 2015 | 210 | 0.120 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 642 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 658 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 968 | 0.110 |
Why?
|
Radiation Tolerance | 1 | 2015 | 486 | 0.110 |
Why?
|
Phenotype | 5 | 2017 | 16301 | 0.110 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4216 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 348 | 0.110 |
Why?
|
Ischemia | 1 | 2021 | 1908 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2017 | 803 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2014 | 676 | 0.100 |
Why?
|
Estrogen Receptor alpha | 1 | 2015 | 575 | 0.100 |
Why?
|
Gene Deletion | 2 | 2015 | 2757 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2017 | 1049 | 0.090 |
Why?
|
Transfection | 2 | 2015 | 5884 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1169 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2021 | 2110 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2013 | 3671 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 774 | 0.090 |
Why?
|
Tamoxifen | 1 | 2014 | 978 | 0.090 |
Why?
|
Haploinsufficiency | 1 | 2011 | 327 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 1285 | 0.090 |
Why?
|
Mutation, Missense | 2 | 2015 | 2552 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2185 | 0.080 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2014 | 643 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2021 | 2737 | 0.080 |
Why?
|
ras Proteins | 1 | 2013 | 1062 | 0.080 |
Why?
|
Genes, BRCA1 | 1 | 2011 | 779 | 0.080 |
Why?
|
Endovascular Procedures | 1 | 2021 | 1947 | 0.080 |
Why?
|
Estrogens | 1 | 2014 | 1561 | 0.080 |
Why?
|
Humans | 29 | 2023 | 739398 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2936 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6569 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 981 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2022 | 16646 | 0.070 |
Why?
|
Signal Transduction | 4 | 2022 | 23355 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2370 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2845 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2901 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2015 | 2634 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2530 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3433 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3694 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5148 | 0.060 |
Why?
|
Cell Movement | 1 | 2015 | 5221 | 0.060 |
Why?
|
Genotype | 2 | 2017 | 12951 | 0.060 |
Why?
|
Alleles | 1 | 2014 | 6942 | 0.050 |
Why?
|
Female | 18 | 2021 | 378853 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5702 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.050 |
Why?
|
RNA Interference | 3 | 2015 | 2899 | 0.050 |
Why?
|
Proteomics | 1 | 2014 | 3584 | 0.050 |
Why?
|
Gene Amplification | 2 | 2017 | 1061 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40050 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4555 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2084 | 0.050 |
Why?
|
Microwaves | 1 | 2021 | 188 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20055 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2021 | 366 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2022 | 501 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15194 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2017 | 1936 | 0.040 |
Why?
|
Gravidity | 1 | 2017 | 51 | 0.040 |
Why?
|
Middle Aged | 9 | 2021 | 212863 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 563 | 0.040 |
Why?
|
Neoplasms | 3 | 2015 | 21507 | 0.040 |
Why?
|
Mice, Nude | 2 | 2014 | 3692 | 0.040 |
Why?
|
Cell Line | 3 | 2015 | 15987 | 0.040 |
Why?
|
Metaplasia | 1 | 2017 | 313 | 0.030 |
Why?
|
Animals | 5 | 2021 | 168368 | 0.030 |
Why?
|
Centromere | 1 | 2017 | 219 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2015 | 4182 | 0.030 |
Why?
|
Microchemistry | 1 | 2015 | 57 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4174 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2015 | 354 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4832 | 0.030 |
Why?
|
Cell Shape | 1 | 2015 | 375 | 0.030 |
Why?
|
Genes, Mitochondrial | 1 | 2014 | 61 | 0.030 |
Why?
|
Parity | 1 | 2017 | 930 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 200 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3571 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23294 | 0.030 |
Why?
|
Cell Respiration | 1 | 2014 | 203 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17384 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1685 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 441 | 0.030 |
Why?
|
Hemolysis | 1 | 2015 | 420 | 0.030 |
Why?
|
Drug Therapy | 1 | 2016 | 497 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 55 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 104 | 0.030 |
Why?
|
Lower Extremity | 1 | 2021 | 1145 | 0.030 |
Why?
|
Risk Factors | 2 | 2021 | 71974 | 0.030 |
Why?
|
Base Sequence | 2 | 2014 | 12804 | 0.030 |
Why?
|
Phosphorylation | 2 | 2014 | 8416 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 401 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 399 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2021 | 62693 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1683 | 0.030 |
Why?
|
Plasma | 1 | 2015 | 573 | 0.030 |
Why?
|
Preoperative Care | 1 | 2021 | 2238 | 0.030 |
Why?
|
Gene Targeting | 1 | 2015 | 886 | 0.030 |
Why?
|
Aneuploidy | 1 | 2015 | 533 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2013 | 417 | 0.030 |
Why?
|
Tubulin | 1 | 2015 | 696 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 546 | 0.030 |
Why?
|
Hysterectomy | 1 | 2017 | 926 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2014 | 853 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 76631 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1010 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1296 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1788 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 721 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 628 | 0.020 |
Why?
|
Placenta | 1 | 2019 | 1682 | 0.020 |
Why?
|
Aged | 6 | 2021 | 162698 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1549 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1093 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14740 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2010 | 126 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1251 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 1994 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1701 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57650 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1356 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1371 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1835 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1264 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9846 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3585 | 0.020 |
Why?
|
Thiazoles | 1 | 2015 | 1488 | 0.020 |
Why?
|
Actins | 1 | 2015 | 2112 | 0.020 |
Why?
|
Mice | 4 | 2017 | 81002 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2430 | 0.020 |
Why?
|
Adult | 6 | 2017 | 213394 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1871 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 581 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5181 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1539 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2013 | 845 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1380 | 0.020 |
Why?
|
Point Mutation | 1 | 2013 | 1626 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3848 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19811 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1528 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1794 | 0.020 |
Why?
|
Pregnancy | 2 | 2019 | 29002 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2183 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3323 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4640 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6133 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1522 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1674 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3498 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5959 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 1537 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6722 | 0.020 |
Why?
|
Homeostasis | 1 | 2015 | 3348 | 0.020 |
Why?
|
Genetic Testing | 1 | 2017 | 3441 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8039 | 0.010 |
Why?
|
Male | 5 | 2021 | 349022 | 0.010 |
Why?
|
United States | 2 | 2021 | 69573 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18125 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3614 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7788 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8274 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14558 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 53037 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 38942 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 10961 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40389 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18003 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9609 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5830 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 28901 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85405 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9622 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15500 | 0.010 |
Why?
|
Transcription Factors | 1 | 2010 | 12120 | 0.010 |
Why?
|